If you want to change selection, open original toplevel document below and click on "Move attachment"
Parent (intermediate) annotation
Open itMetoclopramide is the only drug approved by the FDA for the treatment of gastroparesis; however, metoclopramide is associated with side effects such as hyperprolactinemia, galactorrhea, and tardive dyskinesia that require discontinuation of the drug. Original toplevel document (pdf)
owner:
ELBOMBARDO - (no access) - MKSAP_17.pdf, p2725